Literature DB >> 15368478

Mitochondrial DNA control region sequence variation in migraine headache and cyclic vomiting syndrome.

Qingxue Wang1, Masamichi Ito, Kathleen Adams, B U K Li, Thomas Klopstock, Audrey Maslim, Tomoyasu Higashimoto, Juergen Herzog, Richard G Boles.   

Abstract

Migraine headache is a very common condition affecting about 10% of the population that results in substantial morbidity and economic loss. The two most common variants are migraine with (MA) and without (MO) aura. Often considered to be a migraine-like variant, cyclic vomiting syndrome (CVS) is a predominately childhood condition characterized by severe, discrete episodes of nausea, vomiting, and lethargy. Disease-associated mitochondrial DNA (mtDNA) sequence variants are suggested in common migraine and CVS based upon a strong bias towards the maternal inheritance of disease, and several other factors. Temporal temperature gradient gel electrophoresis (TTGE) followed by cyclosequencing and RFLP was used to screen almost 90% of the mtDNA, including the control region (CR), for heteroplasmy in 62 children with CVS and neuromuscular disease (CVS+) and in 95 control subjects. One or two rare mtDNA-CR heteroplasmic sequence variants were found in six CVS+ and in zero control subjects (P = 0.003). These variants comprised 6 point and 2 length variants in hypervariable regions 1 and 2 (HV1 and HV2, both part of the mtDNA-CR), one half of which were clustered in the nt 16040-16188 segment of HV1 that includes the termination associated sequence (TAS), a functional location important in the regulation of mtDNA replication. Based upon our findings, sequencing and statistical analysis looking for homoplasmic nucleotide changes was performed in HV1 among 30 CVS+, 30 randomly-ascertained CVS (rCVS), 18 MA, 32 MO, and 35 control haplogroup H cases. Within the nt 16040-16188 segment, homoplasmic sequence variants were three-fold more common relative to control subjects in both CVS groups (P = 0.01 combined data) and in MO (P = 0.02), but not in MA (P = 0.5 vs. control subjects and 0.02 vs. MO). No group differences were noted in the remainder of HV1. We conclude that sequence variation in this small "peri-TAS" segment is associated with CVS and MO, but not MA. These variants likely constitute risk factors for disease development. Our findings are consistent with previous data demonstrating progression of CVS into MO in many cases, and the co-segregation in a maternal inheritance pattern of CVS and MO within families. A mitochondrial component in the pathogenesis of migraine and CVS has therapeutic implications, especially concerning the avoidance of fasting. (c) 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15368478     DOI: 10.1002/ajmg.a.30323

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  26 in total

Review 1.  Cyclical vomiting syndrome: Recognition, assessment and management.

Authors:  Michelle Ln Tan; Maria Janelle Liwanag; Seng Hock Quak
Journal:  World J Clin Pediatr       Date:  2014-08-08

Review 2.  A possible role for mitochondrial dysfunction in migraine.

Authors:  S Stuart; L R Griffiths
Journal:  Mol Genet Genomics       Date:  2012-10-07       Impact factor: 3.291

Review 3.  Mitochondrial vasculopathy.

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  World J Cardiol       Date:  2016-05-26

4.  Startle reactivity in children at risk for migraine.

Authors:  Roman Duncko; Lihong Cui; Jeffrey Hille; Christian Grillon; Kathleen R Merikangas
Journal:  Clin Neurophysiol       Date:  2008-10-31       Impact factor: 3.708

Review 5.  Functional gastrointestinal disorders: past and present.

Authors:  Rana Fayez Ammoury; Marian Del Rosario Pfefferkorn; Joseph Marino Croffie
Journal:  World J Pediatr       Date:  2009-07-09       Impact factor: 2.764

6.  A novel syndrome caused by the E410K amino acid substitution in the neuronal β-tubulin isotype 3.

Authors:  Sheena Chew; Ravikumar Balasubramanian; Wai-Man Chan; Peter B Kang; Caroline Andrews; Bryn D Webb; Sarah E MacKinnon; Darren T Oystreck; Jessica Rankin; Thomas O Crawford; Michael Geraghty; Scott L Pomeroy; William F Crowley; Ethylin Wang Jabs; David G Hunter; Patricia E Grant; Elizabeth C Engle
Journal:  Brain       Date:  2013-01-31       Impact factor: 13.501

Review 7.  Pediatric functional gastrointestinal disorders.

Authors:  Mark A McOmber; Robert J Shulman
Journal:  Nutr Clin Pract       Date:  2008 Jun-Jul       Impact factor: 3.080

Review 8.  Genetics and irritable bowel syndrome: from genomics to intermediate phenotype and pharmacogenetics.

Authors:  Michael Camilleri
Journal:  Dig Dis Sci       Date:  2009-08-05       Impact factor: 3.199

Review 9.  Adult cyclical vomiting syndrome: a disorder of allostatic regulation?

Authors:  D J Levinthal; K Bielefeldt
Journal:  Exp Brain Res       Date:  2014-04-16       Impact factor: 1.972

10.  Treatment of cyclic vomiting syndrome with co-enzyme Q10 and amitriptyline, a retrospective study.

Authors:  Richard G Boles; Mary R Lovett-Barr; Amy Preston; B Uk Li; Kathleen Adams
Journal:  BMC Neurol       Date:  2010-01-28       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.